Blood Money: The Faces Behind America's Plasma Economy
The U.S. dominates global plasma collection, supplying 94% of paid donations worldwide through a controversial $35 billion industry. While most nations prohibit compensation for blood products, America allows up to 104 annual 'donations' per person – providing essential medical resources while raising ethical questions about poverty-driven participation.
Cash Flow in White Coats
Eleazar Sanchez, a Mexican immigrant in Texas, typifies the trend: 'I give plasma 8 times a month. The $500 covers bills when work dries up.' His story reflects a system where 80% of donors earn less than $35,000 annually, according to industry data from BioPharma Plasma Group.
Neon Crossroads
The market thrives on necessity:
- 2.69% of U.S. exports are blood products
- Plasma centers clustered in low-income neighborhoods increased 22% since 2020
- Essential for pharmaceuticals treating immune disorders and hemophilia
Critics argue the model exploits vulnerable populations, while advocates note it supports critical healthcare needs. As plasma-derived therapies grow into a projected $45 billion market by 2027, the debate over ethical biomedicine intensifies.
Reference(s):
cgtn.com
